Skip to content

EXTRAPHARM WAREMME

Active Private limited companyfounded 2025active for 1 yearChaussée Romaine 228/A, 4300 WaremmeKBO/BCE: BE 1022.977.341

Lifetime

1 annual account with figures
peak of €64,284 in 2025
€64,284 
lowest -€11,531 in 2025
-€11,531 
peak of -€8,531 in 2025
-€8,531 
€945,397 
peak of 2.7 FTE in 2025
2.7 FTE 
Board1 name since 2025
1 director
Documentsfilings and deeds
09-06-202652 days before the deadline
2025abbreviated format
Loss of €11,531Registered office moved within Waremme 29-08Incorporation 09-051 establishment registeredFirst year with figures

Key points

from the 2025 annual accounts

Equity

-€8,531
2025

Debts exceed assets in financial year 2025.

Turnover

≈ €310,000 estimated

The abbreviated format states no turnover.

Debts

€945,397 101% of the balance sheet
Financial debts 26%Suppliers 21%Taxes and wages 3%Other 49%

Of this, €691,696 falls due within a year.

Board

1 left

1 director left, the latest on 07-10-2026. 1 is in office now.

Position in the sector

-€8,531

Less equity than 89% of companies in retail trade. The sector median is €314,586, over 13,306 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 231 companies had the same profile as EXTRAPHARM WAREMME has now. Each dot is one company, two years later.

96.1%
were still trading
2.2%
stopped another way
1.7%
went bankrupt
  • Micro
  • under 2 years old
  • negative equity
  • a small loss
Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 231 companies, not a prediction for EXTRAPHARM WAREMME. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, , since 01-05-2025
  • founderdeed of 09-05-2025
  • founderdeed of 09-05-2025
  • founderdeed of 09-05-2025
Board & ownership

Recent changes

resigns as director General meeting of 02-09-2026 · Gazette deed
Registered office moved within Waremme The registered office moved from Chaussée Romaine 225 A à 4300 Waremme to CHAUSSÉE ROMAINE 228 A 4300 WAREMME · acts as permanent representative · Board meeting of 01-05-2025 · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:1022977341
Incorporation (director) and (director) appointed · Founded by · Founded by · published on 09-05-2025 · Gazette deed
All 6 events

Comparable companies

same main activity, similar in size and age
Company
EXTRAPHARM WAREMME Waremme €0.9m €64,284 -0.9% 2.7
LA BRABANÇONNE PHARMA Schaerbeek €1.2m €75,175 5.2% 3.1
HealthPharma Léglise €0.9m €103,042 -12.0% 3.4
COSOM Genappe €0.9m €81,043 15.2% -
CHASPIERRE HOLDING Verviers €1.1m €80,882 3.9% -
PHARMA FOCH Montigny-le-Tilleul €0.8m €118,646 1.2% 1.3
ELA SERVICES Uccle €0.9m €66,620 11.8% -

These companies have the same main activity as EXTRAPHARM WAREMME: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €759,000 and €1.2m, founded between 2023 and 2025.

Official details

Source: KBO
Status
Active since 05-05-2025Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730and 5 others
Establishment unit
2.373.377.6874300 Waremme, since 05-05-2025
Financial year end
31 December
Peppol
Reachable since 01-07-2025
Company details

Annual accounts 2025

€936,866
Employeeson 31-12-2025
5
Filing
Filed on 09-06-2026, 52 days before the end of the filing period
Financials

Insights on EXTRAPHARM WAREMME

The 2025 annual accounts show negative equity of -€8,531 and a net result of -€11,531. Its solvency ranks better than 11% of 13,303 sector peers (NACE 47) in financial year 2025.

The company has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about EXTRAPHARM WAREMME

What is the company number of EXTRAPHARM WAREMME?
The company number of EXTRAPHARM WAREMME is 1022.977.341. The VAT number is the same number with BE in front: BE 1022.977.341.
Where is EXTRAPHARM WAREMME based?
The registered office is at Chaussée Romaine 228/A, 4300 Waremme.Company details
What does EXTRAPHARM WAREMME do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of EXTRAPHARM WAREMME?
EXTRAPHARM WAREMME is a private limited company (BV).
When was EXTRAPHARM WAREMME founded?
EXTRAPHARM WAREMME was founded on 05-05-2025.
Is EXTRAPHARM WAREMME still active?
Yes, EXTRAPHARM WAREMME is an active enterprise in the KBO register.
How many employees does EXTRAPHARM WAREMME have?
EXTRAPHARM WAREMME had an average of 2.7 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of EXTRAPHARM WAREMME?
The turnover in financial year 2025 is about €310,000. This figure is estimated from the gross margin of €64,284 and 77 comparable companies (NACE 477). It probably lies between €150,000 and €450,000.
Is EXTRAPHARM WAREMME profitable?
In financial year 2025, EXTRAPHARM WAREMME made a loss of €11,531.
Where can I find the annual accounts of EXTRAPHARM WAREMME?
EXTRAPHARM WAREMME filed 1 annual account with the National Bank of Belgium, for financial year 2025.
When are the next annual accounts of EXTRAPHARM WAREMME due?
EXTRAPHARM WAREMME must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.